Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Menera
- Development stage
- Preclinical
- Lead developer
- Medicinal Technologies
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Menera (also written as MEnera) is an over-the-counter biopharmaceutical and nutraceutical capsule formulation developed by Medicinal Technologies. It is formulated using a proprietary nanocarrier system and contains ubiquinol (the reduced form of Coenzyme Q10) and Lepidium meyenii (maca) root as its active ingredients. Menera is designed to support female reproductive health by balancing reproductive hormones, easing menopausal symptoms, regulating menstrual cycles, and improving fertility and egg quality. It is marketed as an OTC product but is not FDA-approved.
- Brand names
- MEnera
Beyond the preview
Go deeper on Menera.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Menera.